BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 1219628)

  • 1. [Pharmacology of acebutolol in animals].
    Basil B
    Nouv Presse Med; 1975 Dec; 4(46 Suppl):3217-21. PubMed ID: 1219628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the experimental anti-arrhythmic properties of acebutolol (M and B 17,803), propranolol and practolol.
    Basil B; Jordan R; Loveless AH; Maxwell DR
    Br J Pharmacol; 1974 Mar; 50(3):323-33. PubMed ID: 4850183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of acebutolol, a cardioselective beta-adrenoceptor blocking agent, on the blood pressure in rats (author's transl)].
    Takami N; Sugawara K; Ozaki M
    Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):747-54. PubMed ID: 44260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels and beta-adrenoceptor blockade with acebutolol, practolol and propranolol in man.
    Cuthbert MF; Collins RF
    Br J Clin Pharmacol; 1975 Feb; 2(1):49-55. PubMed ID: 1234486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of acebutolol and practolol on the lipolytic response to isoprenaline.
    Gibbons DO; Lant AF; Ashford A; Collins RF; Pinder S
    Br J Clin Pharmacol; 1976 Feb; 3(1):177-84. PubMed ID: 973938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacological properties of dl-2-(3'-t-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl) thiazole hydrochloride (S-596), a new beta-adrenergic blocking agent (author's transl)].
    Hara Y; Sato E; Miyagishi A; Aono S; Nakatani H
    Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):707-20. PubMed ID: 94296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental analysis of the cardiovascular effects of acebutolol, a drug with beta-adrenolytic activity].
    Marmo E; Rossi F; Lampa E; Chieppa S; Apolito A; Del Vecchio F
    Arch Sci Med (Torino); 1978; 135(1):57-78. PubMed ID: 25058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac beta-adrenoceptor blockade: the quest for selectivity.
    Barrett AM
    J Pharmacol; 1985; 16 Suppl 2():95-108. PubMed ID: 2867254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the bronchoconstrictor and beta-adrenoceptor blocking activity of propranolol and acebutolol.
    MacLagan J; Ney UM
    Br J Pharmacol; 1980 Feb; 68(2):196-8. PubMed ID: 6101978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acebutolol, metoprolol and propranolol in conscious dogs with chronic heart-block: chronotropic effects and relation between depression of ventricular activity and beta-adrenoceptor blocking potency.
    Boucher M; Duchene-Marullaz P
    Br J Pharmacol; 1980 Oct; 70(2):335-40. PubMed ID: 6107135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of beta-adrenoceptor selectivity of acebutolol and its metabolite diacetolol with metoprolol and propranolol in normal man.
    Thomas MS; Tattersfield AE
    Eur J Clin Pharmacol; 1986; 29(6):679-83. PubMed ID: 2872056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac and bronchial beta-adrenoceptor antagonistic potencies of atenolol, metoprolol, acebutolol, practolol, propranolol and pindolol in the anaesthetized dog.
    Harms HH; Spoelstra AJ
    Clin Exp Pharmacol Physiol; 1978; 5(1):53-9. PubMed ID: 25152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological properties of diacetolol (M & B 16,942), a major metabolite of acebutolol.
    Basil B; Jordan R
    Eur J Pharmacol; 1982 May; 80(1):47-56. PubMed ID: 6124437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bufuralol, a new beta-adrenoceptor blocking agent in a series of benzofuran-2-ethanolamines. Part 2: pharmacology.
    Hamilton TC; Parkes MW
    Arzneimittelforschung; 1977 Jul; 27(7):1410-7. PubMed ID: 20114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
    Antonaccio MJ; High J; DeForrest JM; Sybertz E
    J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of beta andreoceptor antagonists on the isolated atria of control and of the reserpine treated rabbits.
    Hague MA; Darabi MK; Khalighi MR
    Pahlavi Med J; 1977 Jul; 8(3):326-44. PubMed ID: 21372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The beta-adrenoceptor blocking properties of the alpha-methyl analogues of propranolol and practolol in the anaesthetized dog.
    Levy B
    Br J Pharmacol; 1973 Nov; 49(3):514-26. PubMed ID: 4777711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia.
    Singh BN; Thoden WR; Ward A
    Drugs; 1985 Jun; 29(6):531-69. PubMed ID: 3891306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biochemical studies of acebutolol-the beta1 specificity of acebutolol (author's transl)].
    Hamada Y; Sato I; Ito K; Kuwabara S; Kojima Y
    Nihon Yakurigaku Zasshi; 1977 Jul; 73(5):591-6. PubMed ID: 21835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro studies on the pharmacological properties of diacetolol, the major metabolite of acebutolol in man.
    Borchard U; Hafner D; Hirth C
    Arch Int Pharmacodyn Ther; 1985 Jan; 273(1):4-17. PubMed ID: 2860878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.